Cargando…

Retinal capillary rarefaction in patients with untreated mild-moderate hypertension

BACKGROUND: Microvascular rarefaction influences peripheral vascular resistance, perfusion and metabolism by affecting blood pressure and flow pattern. In hypertension microvascular rarefaction has been described in experimental animal studies as well as in capillaroscopy of skin and biopsies of mus...

Descripción completa

Detalles Bibliográficos
Autores principales: Bosch, Agnes J., Harazny, Joanna M., Kistner, Iris, Friedrich, Stefanie, Wojtkiewicz, Joanna, Schmieder, Roland E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740840/
https://www.ncbi.nlm.nih.gov/pubmed/29268712
http://dx.doi.org/10.1186/s12872-017-0732-x
_version_ 1783288094531780608
author Bosch, Agnes J.
Harazny, Joanna M.
Kistner, Iris
Friedrich, Stefanie
Wojtkiewicz, Joanna
Schmieder, Roland E.
author_facet Bosch, Agnes J.
Harazny, Joanna M.
Kistner, Iris
Friedrich, Stefanie
Wojtkiewicz, Joanna
Schmieder, Roland E.
author_sort Bosch, Agnes J.
collection PubMed
description BACKGROUND: Microvascular rarefaction influences peripheral vascular resistance, perfusion and metabolism by affecting blood pressure and flow pattern. In hypertension microvascular rarefaction has been described in experimental animal studies as well as in capillaroscopy of skin and biopsies of muscle tissue in patients. Retinal circulation mirrors cerebral microcirculation and allows non-invasive investigations. We compared capillary rarefaction of retinal vessels in hypertensive versus normotensive subjects. METHODS: In this study retinal capillary rarefaction in 70 patients with long time (more than 67 month of disease duration) and 64 patients with short time hypertension stage 1 or 2 has been compared to 55 healthy control subjects, who participated in clinical trials in our Clinical Research Center (www.clinicaltrials.gov: NCT01318395, NCT00627952, NCT00152698, NCT01319344). Retinal vascular parameters have been measured non-invasively and in vivo in perfusion image by scanning laser Doppler flowmetry (Heidelberg Engineering, Germany). Capillary rarefaction was assessed by capillary area (CapA) (in pixel-number) and intercapillary distance (ICD) (in μm). Additionally retinal capillary flow (RCF) was measured. RESULTS: ICD was greater in the long time hypertensive group compared to healthy individuals (24.2 ± 6.3 μm vs 20.1 ± 4.2 μm, p = 0.001) and compared to short time hypertensive patients (22.2 ± 5.2 μm, p = 0.020). Long time hypertensive patients showed less CapA compared to healthy people (1462 ± 690 vs 1821 ± 652, p = 0.005). Accordingly, RCF was significantly lower in the long time hypertensive group compared to the healthy control group (282 ± 70 AU vs 314 ± 60 AU, p = 0.032). Our data indicate a lower level of retinal capillary density in hypertensive patients, especially in those with long time hypertension. CONCLUSION: Patients with hypertension stage 1 or 2 showed retinal capillary rarefaction in comparison to healthy normotensive subjects. Retinal capillary rarefaction was intensified with duration of disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12872-017-0732-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5740840
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57408402018-01-03 Retinal capillary rarefaction in patients with untreated mild-moderate hypertension Bosch, Agnes J. Harazny, Joanna M. Kistner, Iris Friedrich, Stefanie Wojtkiewicz, Joanna Schmieder, Roland E. BMC Cardiovasc Disord Research Article BACKGROUND: Microvascular rarefaction influences peripheral vascular resistance, perfusion and metabolism by affecting blood pressure and flow pattern. In hypertension microvascular rarefaction has been described in experimental animal studies as well as in capillaroscopy of skin and biopsies of muscle tissue in patients. Retinal circulation mirrors cerebral microcirculation and allows non-invasive investigations. We compared capillary rarefaction of retinal vessels in hypertensive versus normotensive subjects. METHODS: In this study retinal capillary rarefaction in 70 patients with long time (more than 67 month of disease duration) and 64 patients with short time hypertension stage 1 or 2 has been compared to 55 healthy control subjects, who participated in clinical trials in our Clinical Research Center (www.clinicaltrials.gov: NCT01318395, NCT00627952, NCT00152698, NCT01319344). Retinal vascular parameters have been measured non-invasively and in vivo in perfusion image by scanning laser Doppler flowmetry (Heidelberg Engineering, Germany). Capillary rarefaction was assessed by capillary area (CapA) (in pixel-number) and intercapillary distance (ICD) (in μm). Additionally retinal capillary flow (RCF) was measured. RESULTS: ICD was greater in the long time hypertensive group compared to healthy individuals (24.2 ± 6.3 μm vs 20.1 ± 4.2 μm, p = 0.001) and compared to short time hypertensive patients (22.2 ± 5.2 μm, p = 0.020). Long time hypertensive patients showed less CapA compared to healthy people (1462 ± 690 vs 1821 ± 652, p = 0.005). Accordingly, RCF was significantly lower in the long time hypertensive group compared to the healthy control group (282 ± 70 AU vs 314 ± 60 AU, p = 0.032). Our data indicate a lower level of retinal capillary density in hypertensive patients, especially in those with long time hypertension. CONCLUSION: Patients with hypertension stage 1 or 2 showed retinal capillary rarefaction in comparison to healthy normotensive subjects. Retinal capillary rarefaction was intensified with duration of disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12872-017-0732-x) contains supplementary material, which is available to authorized users. BioMed Central 2017-12-21 /pmc/articles/PMC5740840/ /pubmed/29268712 http://dx.doi.org/10.1186/s12872-017-0732-x Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Bosch, Agnes J.
Harazny, Joanna M.
Kistner, Iris
Friedrich, Stefanie
Wojtkiewicz, Joanna
Schmieder, Roland E.
Retinal capillary rarefaction in patients with untreated mild-moderate hypertension
title Retinal capillary rarefaction in patients with untreated mild-moderate hypertension
title_full Retinal capillary rarefaction in patients with untreated mild-moderate hypertension
title_fullStr Retinal capillary rarefaction in patients with untreated mild-moderate hypertension
title_full_unstemmed Retinal capillary rarefaction in patients with untreated mild-moderate hypertension
title_short Retinal capillary rarefaction in patients with untreated mild-moderate hypertension
title_sort retinal capillary rarefaction in patients with untreated mild-moderate hypertension
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740840/
https://www.ncbi.nlm.nih.gov/pubmed/29268712
http://dx.doi.org/10.1186/s12872-017-0732-x
work_keys_str_mv AT boschagnesj retinalcapillaryrarefactioninpatientswithuntreatedmildmoderatehypertension
AT haraznyjoannam retinalcapillaryrarefactioninpatientswithuntreatedmildmoderatehypertension
AT kistneriris retinalcapillaryrarefactioninpatientswithuntreatedmildmoderatehypertension
AT friedrichstefanie retinalcapillaryrarefactioninpatientswithuntreatedmildmoderatehypertension
AT wojtkiewiczjoanna retinalcapillaryrarefactioninpatientswithuntreatedmildmoderatehypertension
AT schmiederrolande retinalcapillaryrarefactioninpatientswithuntreatedmildmoderatehypertension